BARD1 and breast carcinoma: Unlike BRCA1/2 mutation carriers, bilateral breast cancer was not commonly seen in BARD1 mutation carriers, while 29.8% of the BRCA1 and BRCA2 mutation carriers developed bilateral breast cancers (p-value = 0.039).